Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 2/20 | 0.39 |
| ▸ | PGK2 | P07205 | 2/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.38 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.38 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.38 |
| ▸ | HTR2C | P28335 | 2/20 | 0.38 |
| ▸ | HTR2B | P41595 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.38 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31085146 | 0.87 | UGT2B7 (0.39) | PGK1PGK2GABRA1GABRG2GABRB3 | |
| SCHEMBL18857235 | 0.87 | PGK1 (0.33) | PGK1PGK2GABRA1GABRG2GABRB3 | |
| SCHEMBL19889437 | 0.87 | PGK1 (0.33) | PGK1PGK2GABRA1GABRG2GABRB3 | |
| SCHEMBL9232328 | 0.87 | UGT2B7 (0.39) | PGK1PGK2GABRA1GABRG2GABRB3 | |
| SCHEMBL21649830 | 0.87 | PGK1 (0.42) | PGK1PGK2GABRA1GABRG2GABRB3 | |
| SCHEMBL12922238 | 0.86 | CCR1 (0.46) | GABRA1GABRG2GABRB3HTR2CHTR2B | |
| SCHEMBL12915226 | 0.85 | CHRNA7 (0.33) | PGK1PGK2GABRA1GABRG2GABRB3 | |
| SCHEMBL30577788 | 0.84 | IRAK4 (0.41) | PGK1PGK2GABRA1GABRG2GABRB3 | |
| SCHEMBL906775 | 0.84 | IRAK4 (0.41) | PGK1PGK2GABRA1GABRG2GABRB3 | |
| SCHEMBL102150 | 0.84 | CCR1 (0.50) | LMNACYP1A2CYP3A4HPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 759 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4720083-A1 | FUNCTIONALIZED TETRAHYDROFURAN INTERMEDIATE AND SYNTHESIS THEREOF | Quralis Corporation (US) | 2026-04-08 | — | — | EP | claimed |
| WO-2025217072-A1 | HIGH DART IMPACT AND TEAR FILMS FROM TITANIUM BASED PREPOLYMER CATALYZED POLYETHYLENES | FORMOSA PLASTICS CORPORATION, USA (US) | 2025-10-16 | — | — | WO | claimed |
| WO-2024249886-A1 | FUNCTIONALIZED TETRAHYDROFURAN INTERMEDIATE AND SYNTHESIS THEREOF | QURALIS CORPORATION (US) | 2024-12-05 | — | — | WO | claimed |
| CN-113912635-A | Method for preparing homoallylic silicon derivative by iron catalysis | 中国科学院大连化学物理研究所 | 2022-01-11 | — | — | CN | claimed |
| CN-113754694-A | Method for synthesizing Reidesvir by asymmetric catalysis of non-protecting group nucleoside | 上海交通大学 | 2021-12-07 | — | — | CN | claimed |
| CN-108383729-A | A kind of purposes of organic base as catalyst carbonate synthesis dibasic ester | 中国海洋石油集团有限公司 | 2018-08-10 | — | — | CN | claimed |
| CN-106543078-A | A kind of preparation method of quinoline | 中国科学院兰州化学物理研究所苏州研究院 | 2017-03-29 | — | — | CN | claimed |
| US-20060287309-A1 | [1,8]NAPHTHYRIDIN-2-ONES AND RELATED COMPOUNDS FOR THE TREATMENT OF SCHIZOPHRENIA | WARNER-LAMBERT COMPANY LLC | 2006-12-21 | — | — | US | claimed |
| US-20060287310-A1 | [1,8]NAPHTHYRIDIN-2-ONES AND RELATED COMPOUNDS FOR THE TREATMENT OF SCHIZOPHRENIA | WARNER-LAMBERT COMPANY LLC | 2006-12-21 | — | — | US | claimed |
| US-20050043309-A1 | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia | WARNER-LAMBERT COMPANY LLC | 2005-02-24 | — | — | US | claimed |
| US-4212937-A | NITROGEN-CONTAINING HETEROCYCLIC BASE | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1980-07-15 | — | — | US | claimed |
| WO-2026100259-A1 | RADIATION-SENSITIVE COMPOSITION, PATTERN FORMATION METHOD, AND COMPOUND | JSR株式会社 | 2026-05-15 | — | — | WO | disclosed |
| US-20260098105-A1 | PREPOLYMERIZED CATALYST FOR OLEFIN POLYMERIZATION, METHOD OF PRODUCING THIS PREPOLYMERIZED CATALYST AND METHOD OF PRODUCING OLEFIN POLYMER WITH IMPROVED PROCESSABILITY AND OPTICAL PROPERTIES | FORMOSA PLASTICS CORPORATION, U.S.A. (US) | 2026-04-09 | — | — | US | disclosed |
| EP-4720083-A1 | FUNCTIONALIZED TETRAHYDROFURAN INTERMEDIATE AND SYNTHESIS THEREOF | Quralis Corporation (US) | 2026-04-08 | — | — | EP | disclosed |
| WO-2025217072-A1 | HIGH DART IMPACT AND TEAR FILMS FROM TITANIUM BASED PREPOLYMER CATALYZED POLYETHYLENES | FORMOSA PLASTICS CORPORATION, USA (US) | 2025-10-16 | — | — | WO | disclosed |
| EP-0193280-A2 | Catalyst component for olefin polymerization | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1986-09-03 | — | — | EP | disclosed |
| EP-0187034-A2 | Process for producing poly-1-butene | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1986-07-09 | — | — | EP | disclosed |
| EP-0157472-A1 | Process for polymerization of olefins | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1985-10-09 | — | — | EP | disclosed |
| EP-0156512-A1 | Process for preparing catalyst component for polymerization of olefins | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1985-10-02 | — | — | EP | disclosed |
| US-4212937-A | NITROGEN-CONTAINING HETEROCYCLIC BASE | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1980-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050043309-A1 | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia | DRD1, DRD2, DRD3 | PGK1 2015/4885PGK2 2115/4885GABRA1 915/4885 |
| US-20260098105-A1 | PREPOLYMERIZED CATALYST FOR OLEFIN POLYMERIZATION, METHOD OF PRODUCING THIS PREPOLYMERIZED CATALYST AND METHOD OF PRODUCING OLEFIN POLYMER WITH IMPROVED PROCESSABILITY AND OPTICAL PROPERTIES | DIS3, DRD4, SRP54 | PGK1 1897/4885PGK2 3258/4885GABRA1 4571/4885 |
| US-20060287309-A1 | [1,8]NAPHTHYRIDIN-2-ONES AND RELATED COMPOUNDS FOR THE TREATMENT OF SCHIZOPHRENIA | DRD1, DRD2, DRD3 | PGK1 2015/4885PGK2 2115/4885GABRA1 915/4885 |
| US-20060287310-A1 | [1,8]NAPHTHYRIDIN-2-ONES AND RELATED COMPOUNDS FOR THE TREATMENT OF SCHIZOPHRENIA | DRD1, DRD2, DRD3 | PGK1 2015/4885PGK2 2115/4885GABRA1 915/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.